RSFTSTYL'DNeoplasia  !LpqrstxXyz{  ,!|$  and !x\yzd{ , !|$ , and !u@}~  , et al.vw ---!"HpqrstxXyz{  , !|$ , and !xXydzd{  , !|$  and !u@}~, et al.vw ---!#\t   ! t    !   (! ). !t    .!h   t   ! t   ,! t   .! t    . !   (! ). !h      ,!( Edition!  , ,Volume!      ,!, ,ed.^eds.!t    (!     :!  )!t   .! t    . !   (! ). !h    $ .In!D  .!0"(#$%&    !, ,Ed.^Eds.!    !  , !h    | $ .pp.! t   .! hXt    !   (! ). !h   | $ .In!     ,!, ,ed.^eds.!t    (!     :!  )!| $ ,pp.! t   .! $p@   [!  ] !t   ! t   ! %|t   ! ' the basis for the development of anxA5 as a diagnostic tool. Within this context, the clinical relevance, limitations, and future perspectives of this approach of visualizing cell death are d&e(0  ,!213@   [!  ]!4<pqrstx\yz{  and!|$  and !xXydzd{  , !|$  and !u@}~ et al.vw 5on aspects of anxA5 are reviewed and discussed in this article. Radiolabeled anxA5 bears the promise of becoming a clinically applied radiopharmaceutical with potential applications in cardiology and 64  -!74  ; !8@}~ et al.9:;  , !<=>?@PQZ  , !RSHpqrstxXyzd{  , !|$  and !xXydzd{  , !|$  and !u@}~, et al.vw ---!THpqrstxXyzd{  , !|$  and !xXydzd{  , !|$  and !u@}~, et al.vw ---!UVWY$ Ibid.!$ Ibid.!   `ab<dc, Anonymous!(@ABC `